RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Due Diligence in the Life Science Industry

Due Diligence in the Life Science Industry

Posted 01 July 2009

Due diligence is the act of reviewing information to ascertain the value of data presented by checking for compliance and/or investigate the desirability, value and potential of an investment. Due diligence should be performed prior to any merger or acquisition to determine whether information about the target company is correct, accurate and properly disclosed. It can also be carried out on a smaller scale before, for example, buying assets or products from another company, licensing or acquiring a technology, or acquiring a division. The review may encompass the company's financial, legal, labor, tax, IT and commercial situation and may include such areas as intellectual property, real and personal property, insurance and liability coverage, among others.11

 

© 2022 Regulatory Affairs Professionals Society.